Overview of GMMG-HD3 Schmidt-Wolf, Bonn Bone Disease
MEETING OF THE GERMAN-SPEAKING MYELOMA MULTICENTER GROUP (GMMG)
Friday, September 26, 2003
Noon to 5:30 PM
I. Breitkreutz, Heidelberg
H. Goldschmidt, Heidelberg
Scientific Program GMMG HD3
P.Liebisch, Ulm
F.W. Cremer, Heidelberg
R. Bartl, München
B. Klein, Montpellier
Overview of HOVON
H. Lokhorst, Utrecht
Relapse Study TCID
A. Glasmacher, Bonn
Relapse Study TCED
Th. Moehler, Heidelberg
Central European Study Group
H. Ludwig, Wien
NMAM-2000 EBMT-Study
G. Gahrton, Huddinge
TPX in Elderly Patients
W. Knauf, Berlin
Revimid-Phase-III-Study
TBA
Velcade-Phase-III-Study
H. Goldschmidt, Heidelberg
Velcade-Phase-II-Study
Kropf, Muenster
Bisphosponates plus IL-2
Kunzmann, Wuerzburg
Ribomustin plus Thal
W. Poenisch, Leipzig
Dinner in Vinery
7:00 pm
WORKSHOP "NEW DRUGS AND TRANSPLANTATION IN MULTIPLE MYELOMA
Saturday September 27, 2003
8:00 AM to 3:00 PM
New Drugs in Multiple Myeloma
Chairs: Durie/Bartl/Ho
Thalidomide
Goldschmidt, Heidelberg
Revimid
Durie, Los Angeles
Velcade
TBA
Arsen
Ludwig, Wien
New Bisphosphonates
Bartl, München
Transplantation of Hematopoietic Cells
Chairs: Gahrton/Lokhorst/Goldschmidt
Autologous SCT after HD-Therapy
Goldschmidt, Heidelberg
Autologous SCT after Intermediate Therapy
TBA
Allogeneic SCT after HD-Therapy
Gahrton, Huddinge
Allogenic SCT after Intermediate Therapy
Kröger, Hamburg
Role of T-Cells
Lokhorst, Utrecht
SEMINAR OF THE INTERNATIONAL MYELOMA FOUNDATION
Saturday September 27,2003
3:00 PM to 7:00 PM
Opening
A.D. Ho
Welcome
S. Novis
A. Waldmannn, J. Brosig
DLH
Diagnosis and Prognostic Factors
B. Durie
Conventional Therapy
H. Ludwig
Autologous Transplantation
H. Goldschmidt
Allogeneic Transplantation
G. Gahrton
Dinner at German Cancer Center
7:00 pm
Sunday September 28, 2003,
9:00 AM to 2:00 PM
R. Bartl
Anaemia and Supportive Care
A. Glasmacher
Psycho-Oncological Support
Verres
Alternative Treatment Modalities
TBA
New drugs and treatment options
B. Durie
The importance of clinical trials
Seibert-Grafe
Rehabilitation
Stenzinger
Ask the Expert
All Speakers
Closing Remarks
S. Novis